Literature DB >> 26116263

Clinical color vision testing and correlation with visual function.

Jiawei Zhao1, Sarita B Davé1, Jiangxia Wang1, Prem S Subramanian2.   

Abstract

PURPOSE: To determine if Hardy-Rand-Rittler (H-R-R) and Ishihara testing are accurate estimates of color vision in subjects with acquired visual dysfunction.
DESIGN: Assessment of diagnostic tools.
METHODS: Twenty-two subjects with optic neuropathy (aged 18-65) and 18 control subjects were recruited prospectively from an outpatient clinic. Individuals with visual acuity (VA) <20/200 or with congenital color blindness were excluded. All subjects underwent a comprehensive eye examination including VA, color vision, and contrast sensitivity testing. Color vision was assessed using H-R-R and Ishihara plates and Farnsworth D-15 (D-15) discs. D-15 is the accepted standard for detecting and classifying color vision deficits. Contrast sensitivity was measured using Pelli-Robson contrast sensitivity charts.
RESULTS: No relationship was found between H-R-R and D-15 scores (P = .477). H-R-R score and contrast sensitivity were positively correlated (P = .003). On multivariate analysis, contrast sensitivity (β = 8.61, P < .001) and VA (β = 2.01, P = .022) both showed association with H-R-R scores. Similar to H-R-R, Ishihara score did not correlate with D-15 score (P = .973), but on multivariate analysis was related to contrast sensitivity (β = 8.69, P < .001). H-R-R and Ishihara scores had an equivalent relationship with contrast sensitivity (P = .069).
CONCLUSION: Neither H-R-R nor Ishihara testing appears to assess color identification in patients with optic neuropathy. Both H-R-R and Ishihara testing are correlated with contrast sensitivity, and these tests may be useful clinical surrogates for contrast sensitivity testing.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26116263     DOI: 10.1016/j.ajo.2015.06.015

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  10 in total

1.  Dyschromatopsia in Multiple Sclerosis Patients: A Marker of Subclinical Involvement?: Comment.

Authors:  Prem S Subramanian; Jiawei Zhao; Sarita B Davé; Jiangxia Wang
Journal:  J Neuroophthalmol       Date:  2017-03       Impact factor: 3.042

2.  A method for identifying color vision deficiency malingering.

Authors:  Andrew Pouw; Rustum Karanjia; Alfredo Sadun
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-12-21       Impact factor: 3.117

3.  Effects of Contrast Sensitivity on Colour Vision Testing.

Authors:  Anvesh Annadanam; Jiawei Zhao; Jiangxia Wang; Allen O Eghrari
Journal:  Neuroophthalmology       Date:  2017-05-19

4.  Diffuse Colour Discrimination as Marker of Afferent Visual System Dysfunction in Amyotrophic Lateral Sclerosis.

Authors:  Lindsay Boven; Qin Li Jiang; Heather E Moss
Journal:  Neuroophthalmology       Date:  2017-06-01

5.  Comparison of a Smartphone Application with Ishihara Pseudoisochromatic Plate for Testing Colour Vision.

Authors:  Jiawei Zhao; Michael Joseph Fliotsos; Mehrnaz Ighani; Allen O Eghrari
Journal:  Neuroophthalmology       Date:  2018-11-19

6.  A Novel Smartphone-Based Color Test for Detection of Color Vision Defects in Age Related Macular Degeneration.

Authors:  Vassilios Karampatakis; Diamantis Almaliotis; Leonidas Karamitopoulos; George Kalliris; Stavroula Almpanidou
Journal:  J Ophthalmol       Date:  2022-03-31       Impact factor: 1.909

Review 7.  Visual function tests for glaucoma practice - What is relevant?

Authors:  Aparna Rao; Debananda Padhy; Anindita Pal; Avik Kumar Roy
Journal:  Indian J Ophthalmol       Date:  2022-03       Impact factor: 2.969

8.  Evaluation of the Reddesa Chart, a New Red Desaturation Testing Method, for Optic Neuritis Screening and Grading in Clinical Routine.

Authors:  Dominik Bruegger; Anna-Lucia Koth; Muriel Dysli; David Goldblum; Mathias Abegg; Markus Tschopp; Christoph Tappeiner
Journal:  Front Neurol       Date:  2022-07-07       Impact factor: 4.086

9.  Genes Relevant to Tissue Response to Cancer Therapy Display Diurnal Variation in mRNA Expression in Human Oral Mucosa.

Authors:  Fangyi Gu; Eduardo Cortes Gomez; Jianhong Chen; Matthew F Buas; Nicolas F Schlecht; Karen Hulme; Shweta Vishwas Kulkarni; Prashant K Singh; Richard O'Connor; Christine B Ambrosone; Anurag K Singh; Jianmin Wang
Journal:  J Circadian Rhythms       Date:  2021-06-17

10.  Visual Acuity Inadequately Reflects Vision-Related Quality of Life in Patients After Macula-Off Retinal Detachment Surgery.

Authors:  Heijan Ng; Koenraad A Vermeer; Jan C van Meurs; Ellen C La Heij
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-08-03       Impact factor: 4.799

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.